| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 1,390 | $110 | $150.4K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 590 | $80 | $45.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 210 | $140 | $30.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 150 | $110 | $16.5K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 80 | $180 | $14.1K |
| J0185 | Injection, aprepitant, 1 mg | 12,220 | $1 | $12.2K |
| 96416 | The provider starts treatment for administering a chemotherapy drug to a patient intravenously using a portable or implantable pump. | 70 | $110 | $7.1K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 110 | $50 | $5.9K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 350 | $10 | $4.5K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 160 | $20 | $3.9K |